Artal Group S.A. Agios Pharmaceuticals, Inc. Call Options Transaction History

Artal Group S.A.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 09, 2019	SELL	$46.17 - $68.1 $4.62 Million - $6.81 Million	-100,000 Reduced 50.0%	100,000 $4.99 Million
Q4 2018 Feb 11, 2019	BUY	$42.73 - $76.53 $6.41 Million - $11.5 Million	150,000 Added 300.0%	200,000 $9.22 Million
Q1 2018 May 10, 2018	SELL	$59.83 - $86.53 $2.99 Million - $4.33 Million	-50,000 Reduced 50.0%	50,000 $4.09 Million
Q4 2017 Feb 09, 2018	BUY	$52.12 - $72.33 $5.21 Million - $7.23 Million	100,000	100,000 $5.72 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.